Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationship

Article abstract of DOI:10.1248/cpb.48.1964

Based on structure-activity relationship studies, we designed and synthesized plasmin (PL) and plasma kallikrein (PK) inhibitors. Trans-(4-aminomethylcyclohexanecarbonyl)-Tyr(O-PIC)-octylamide inhibited PL, PK, urokinase (UK) and thrombin (TH) with IC₅₀ values of 0.53, 30, 5.3 and >400 μM, respectively. Trans-(4-aminomethylcyclohexanecarbonyl)-Tyr(O-2-Pyrim)-4-carboxyanilide inhibited PL, PK, UK and TH with IC₅₀ values of 36, 0.56, 440 and >1000 μM, respectively.